N-Methylaspartate

adaptor related protein complex 5 subunit beta 1 ; Homo sapiens







44 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33765560 Involvement of NMDA and GABA(A) receptors in modulation of spontaneous activity in hippocampal culture: Interrelations between burst firing and intracellular calcium signal. 2021 May 14 1
2 27589479 Supraspinal control of spinal reflex responses to body bending during different behaviours in lampreys. 2017 Feb 1 1
3 23665343 Investigations into the involvement of NMDA mechanisms in recognition memory. 2013 Nov 1
4 19462233 Different mechanisms of NMDA-mediated protection against neuronal apoptosis: a stimuli-dependent effect. 2009 Nov 1
5 16107147 Development of a three-dimensional model for the N-methyl-D-aspartate NR2A subunit. 2005 Aug 25 1
6 14725968 Activation of long-term synaptic plasticity causes suppression of epileptiform activity in rat hippocampal slices. 2004 Feb 13 1
7 12728252 Seizure-like activity leads to the release of BAD from 14-3-3 protein and cell death in hippocampal neurons in vitro. 2003 May 1
8 12969750 Evidence for a glutamatergic modulation of the cholinergic function in the human enteric nervous system via NMDA receptors. 2003 Aug 22 1
9 11166686 The regulation of NMDA-evoked dopamine release by nitric oxide in the frontal cortex and raphe nuclei of the freely moving rat. 2001 Jan 19 1
10 11554552 NMDA receptors and learning and memory processes. 2001 Sep 1
11 9570791 Region-specific and calcium-dependent increase in dialysate choline levels by NMDA. 1998 May 15 2
12 9601691 AMPA and NMDA receptor-dependent spinal LTP after nociceptive tetanic stimulation. 1998 Apr 20 1
13 9744485 N-methyl-D-aspartic acid stimulation of vasopressin release: role in osmotic regulation and modulation by gonadal steroids. 1998 Sep 1
14 9774257 Sustained exposure to a glycine receptor partial agonist differentially alters NMDA receptor agonist and antagonist potencies in cultured spinal cord neurons. 1998 Sep 4 2
15 8782887 Opioids modulate N-methyl-D-aspartic acid (NMDA)-evoked responses of neurons in the superficial and deeper dorsal horn of the medulla (trigeminal nucleus caudalis). 1996 May 6 1
16 8957213 The ventral subiculum modulation of prepulse inhibition is not mediated via dopamine D2 or nucleus accumbens non-NMDA glutamate receptor activity. 1996 Oct 24 2
17 8978823 Functional N-methyl-D-aspartate receptors in O-2A glial precursor cells: a critical role in regulating polysialic acid-neural cell adhesion molecule expression and cell migration. 1996 Dec 1
18 7589322 NMDA and non-NMDA receptors contribute to synaptic transmission between the medial geniculate body and the lateral nucleus of the amygdala. 1995 2
19 8563977 HIV-1 envelope proteins gp120 and gp160 potentiate NMDA-induced [Ca2+]i increase, alter [Ca2+]i homeostasis and induce neurotoxicity in human embryonic neurons. 1995 Nov 1 1
20 8728878 [Role of excitatory amino acids in neuropathology]. 1995 1
21 7697879 Developmental alterations in the sensitivity of hippocampal NMDA receptors to AP5. 1994 Dec 16 2
22 7830958 NMDA receptors on adult frog spinal motoneurons in culture. 1994 Aug 1 1
23 7931537 Kinetics of AP5 dissociation from NMDA receptors: evidence for two identical cooperative binding sites. 1994 Jun 2
24 7956307 Excitatory amino acid receptors in membranes from cultured human retinal pigment epithelium. 1994 Aug 2
25 7993305 Intrahippocampal administration of both the D- and the L-isomers of AP5 disrupt spontaneous alternation behavior and evoked potentials. 1994 Sep 2
26 7906555 Activation of NMDA receptors increases brain-derived neurotrophic factor (BDNF) mRNA expression in the hippocampal formation. 1993 Nov 18 1
27 8136044 Fear-potentiated startle: a neural and pharmacological analysis. 1993 Dec 20 1
28 8257926 Pharmacological analysis of fear-potentiated startle. 1993 Mar 1
29 1279472 Single-channel currents of NMDA type activated by L- and D-homocysteic acid in cerebellar granule cells in culture. 1992 Jul 20 1
30 1336704 Activation of locus coeruleus neurons by nucleus paragigantocellularis or noxious sensory stimulation is mediated by intracoerulear excitatory amino acid neurotransmission. 1992 Dec 11 1
31 1347562 Extinction of fear-potentiated startle: blockade by infusion of an NMDA antagonist into the amygdala. 1992 Mar 1
32 1356242 Competitive NMDA receptor antagonists raise electrically kindled generalized seizure thresholds. 1992 May 2
33 1363482 A simple method for electrical field stimulation of cultured granule cells. 1992 Dec 1
34 1387617 Heterogeneity of NMDA receptors labelled with [3H]3-((+-)-2-carboxypiperazin-4-yl) propyl-1-phosphonic acid ([3H]CPP): receptor status in Alzheimer's disease brains. 1992 Mar 12 1
35 1533422 Generation of N-methyl-D-aspartate agonist and competitive antagonist pharmacophore models. Design and synthesis of phosphonoalkyl-substituted tetrahydroisoquinolines as novel antagonists. 1992 Apr 17 1
36 1671413 Synthesis and biological evaluation of cyclopropyl analogues of 2-amino-5-phosphonopentanoic acid. 1991 Jan 1
37 1717306 Avian locomotion activated by brainstem infusion of neurotransmitter agonists and antagonists. I. Acetylcholine excitatory amino acids and substance P. 1991 1
38 1972778 Blocking of acquisition but not expression of conditioned fear-potentiated startle by NMDA antagonists in the amygdala. 1990 Jun 21 1
39 1972782 Postsynaptic NMDA receptor-mediated calcium accumulation in hippocampal CA1 pyramidal cell dendrites. 1990 Jun 28 1
40 1975660 The glycine site modulates NMDA-mediated changes of intracellular free calcium in cultures of hippocampal neurons. 1990 Jul 3 1
41 2543255 Selective vulnerability of the brain: new insights into the pathophysiology of stroke. 1989 Jun 15 1
42 2564302 Effect of central administration of phencyclidine on plasma concentrations of luteinizing hormone. 1989 Jan 30 1
43 2837634 Multiple sites for the regulation of the N-methyl-D-aspartate receptor. 1988 Jun 2
44 2893414 Phencyclidine (PCP)-like discriminative stimulus effects of metaphit and of 2-amino-5-phosphonovalerate in pigeons: generality across different training doses of PCP. 1987 2